Evaluating the Efficacy of Diltiazem Gel in Reducing the Complications and Pain in Anorectal Operations

Evaluation of the effectiveness of diltiazem gel in reducing complications and pain of anorectal surgery in patients candidates for anorectal surgery

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120118008769N5

Enrollment

144

Registered

2021-11-28

Start date

2020-04-20

Completion date

Unknown

Last updated

2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anorectal surgery. Anorectal fistula

Interventions

Intervention 1: Intervention group: Group receiving 2% diltiazem gel from Sobhan Pharmaceutical Company, one applicator immediately after surgery and every eight hours for the first 24 hours after ano

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Candidates for anorectal surgery Informed consent

Exclusion criteria

Exclusion criteria: Pregnant women Sensitivity to diltiazem gel

Design outcomes

Primary

Measure	Time frame
Postoperative pain score. Timepoint: Immediately after surgery then every 8 hours to 24 hours. Method of measurement: Visual Analogue Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed Jalal eshaqh Hoseini

Ghoum University of Medical Sciences

J.hosseni@muq.ac.ir+98 25 3612 2827

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026